Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1991 Aug 25;19(16):4355–4359. doi: 10.1093/nar/19.16.4355

Molecular heterogeneity of the fragile X syndrome.

Y Nakahori 1, S J Knight 1, J Holland 1, C Schwartz 1, A Roche 1, J Tarleton 1, S Wong 1, T J Flint 1, U Froster-Iskenius 1, D Bentley 1
PMCID: PMC328620  PMID: 1886762

Abstract

The fragile X syndrome is an X-linked disorder which has been shown to be associated with the length variation of a DNA fragment containing a CGG trinucleotide repeat element at or close to the fragile site. Phenotypically normal carriers of the disorder generally have a smaller length variation than affected individuals. We have cloned the region in cosmids and defined the area containing the amplified sequence. We have used probes from the region to analyse the mutation in families. We show that the mutation evolves in different ways in different individuals of the same family. In addition we show that not all fragile X positive individuals show this amplification of DNA sequence even though they show expression of the fragile site at levels greater than 25%. One patient has alterations in the region adjacent to the CGG repeat elements. Three patients in fragile X families have the normal fragment with amplification in a small population of their cells. These observations indicate that there is molecular heterogeneity in the fragile X syndrome and that the DNA fragment length variation is not the only sequence responsible for the expression of the fragile site or the disease phenotype.

Full text

PDF
4355

Images in this article

4356Image
on p.4356
4357Image
on p.4357
4357Image
on p.4357
4358Image
on p.4358
4358Image
on p.4358

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell M. V., Hirst M. C., Nakahori Y., MacKinnon R. N., Roche A., Flint T. J., Jacobs P. A., Tommerup N., Tranebjaerg L., Froster-Iskenius U. Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell. 1991 Feb 22;64(4):861–866. doi: 10.1016/0092-8674(91)90514-y. [DOI] [PubMed] [Google Scholar]
  2. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  3. Hirst M. C., Rack K., Nakahori Y., Roche A., Bell M. V., Flynn G., Christadoulou Z., MacKinnon R. N., Francis M., Littler A. J. A YAC contig across the fragile X site defines the region of fragility. Nucleic Acids Res. 1991 Jun 25;19(12):3283–3288. doi: 10.1093/nar/19.12.3283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hirst M. C., Roche A., Flint T. J., MacKinnon R. N., Bassett J. H., Nakahori Y., Watson J. E., Bell M. V., Patterson M. N., Boyd Y. Linear order of new and established DNA markers around the fragile site at Xq27.3. Genomics. 1991 May;10(1):243–249. doi: 10.1016/0888-7543(91)90506-a. [DOI] [PubMed] [Google Scholar]
  5. Kähkönen M., Alitalo T., Airaksinen E., Matilainen R., Launiala K., Autio S., Leisti J. Prevalence of the fragile X syndrome in four birth cohorts of children of school age. Hum Genet. 1987 Sep;77(1):85–87. doi: 10.1007/BF00284720. [DOI] [PubMed] [Google Scholar]
  6. Lubs H. A. A marker X chromosome. Am J Hum Genet. 1969 May;21(3):231–244. [PMC free article] [PubMed] [Google Scholar]
  7. Nussbaum R. L., Airhart S. D., Ledbetter D. H. Recombination and amplification of pyrimidine-rich sequences may be responsible for initiation and progression of the Xq27 fragile site: an hypothesis. Am J Med Genet. 1986 Jan-Feb;23(1-2):715–721. doi: 10.1002/ajmg.1320230162. [DOI] [PubMed] [Google Scholar]
  8. Pembrey M. E., Winter R. M., Davies K. E. A premutation that generates a defect at crossing over explains the inheritance of fragile X mental retardation. Am J Med Genet. 1985 Aug;21(4):709–717. doi: 10.1002/ajmg.1320210413. [DOI] [PubMed] [Google Scholar]
  9. Sherman S. L., Jacobs P. A., Morton N. E., Froster-Iskenius U., Howard-Peebles P. N., Nielsen K. B., Partington M. W., Sutherland G. R., Turner G., Watson M. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet. 1985;69(4):289–299. doi: 10.1007/BF00291644. [DOI] [PubMed] [Google Scholar]
  10. Sherman S. L., Morton N. E., Jacobs P. A., Turner G. The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet. 1984 Jan;48(Pt 1):21–37. doi: 10.1111/j.1469-1809.1984.tb00830.x. [DOI] [PubMed] [Google Scholar]
  11. Sutherland G. R. Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science. 1977 Jul 15;197(4300):265–266. doi: 10.1126/science.877551. [DOI] [PubMed] [Google Scholar]
  12. Temple I. K., Baraitser M., Pembrey M. E., Butler L., Jacobs P., Davies K. E. Unusual presentation of fragile X syndrome. Lancet. 1990 Nov 3;336(8723):1131–1131. doi: 10.1016/0140-6736(90)92608-k. [DOI] [PubMed] [Google Scholar]
  13. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  14. Vincent A., Heitz D., Petit C., Kretz C., Oberlé I., Mandel J. L. Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis. Nature. 1991 Feb 14;349(6310):624–626. doi: 10.1038/349624a0. [DOI] [PubMed] [Google Scholar]
  15. Webb T. P., Bundey S., Thake A., Todd J. The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet. 1986 Oct;23(5):396–399. doi: 10.1136/jmg.23.5.396. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES